MDIT - Medite Cancer Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.47M
Enterprise Value 3
9.82M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.53
Enterprise Value/Revenue 3
1.21
Enterprise Value/EBITDA 6
-2.63

Trading Information

Stock Price History

Beta (5Y Monthly) 3.24
52-Week Change 3100.00%
S&P500 52-Week Change 325.98%
52 Week High 30.1200
52 Week Low 30.0100
50-Day Moving Average 30.0206
200-Day Moving Average 30.0391

Share Statistics

Avg Vol (3 month) 35.33k
Avg Vol (10 day) 313.07k
Shares Outstanding 586.72M
Float 17.31M
% Held by Insiders 156.94%
% Held by Institutions 19.61%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Mar 11, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2017
Most Recent Quarter (mrq)Sep 29, 2018

Profitability

Profit Margin -65.49%
Operating Margin (ttm)-49.34%

Management Effectiveness

Return on Assets (ttm)-13.68%
Return on Equity (ttm)-73.70%

Income Statement

Revenue (ttm)8.13M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)42.00%
Gross Profit (ttm)162k
EBITDA -3.73M
Net Income Avi to Common (ttm)-5.42M
Diluted EPS (ttm)-0.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)90k
Total Cash Per Share (mrq)0
Total Debt (mrq)6.05M
Total Debt/Equity (mrq)94.00
Current Ratio (mrq)1.11
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-5.19M
Levered Free Cash Flow (ttm)-2.44M